low-dose glucocorticoids
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for low-dose glucocorticoids, covering 2022-11-04 to 2022-11-04. Get the full timeline:
Most recent: Clinical Trial Update: To Compare the Efficacy and Safety of Low-dose Glucocorticoids and Tofacitinib in Alleviating Moderate to High Disease Activity Rheumatoid Arthritis for 24 Weeks [Phase 4]